J Korean Soc Plast Reconstr Surg.  2004 May;31(3):337-342.

Application of 2-Octylcyanoacrylate (Dermabond(R) for Laceration Repair in Emergency Department

  • 1Department of Plastic and Reconstructive Surgery, Emergency Medicine, Korea.
  • 2Bundang CHA General Hospital, College of Medicine, Pochon CHA University, Kyonggi, Korea. sykang@cha.ac.kr


A retrospective, randomized controlled clinical trial to assess the effectiveness of Dermabond(r) for repair of traumatic laceration in 86 patients, who signed the informed consent, was studied. Patient selection was limited to facial laceration, less than 2cm in length, non-contaminated, non-bitten, and non-crushed lacerations. All of 86 patients were available for the primary follow-up within 7 to 10 days after Dermabond(r) application and the survey was carried out for outcomes of cosmesis, pain, complications and cost. 76 patients (88%) were satisfied and 10 patients(12%) were dissatisfied with Dermabond(r) application. All of 10 unsatisfied patients had complication, such as wound dehiscence in 6 patients, depressed scar in 2 patients, skin necrosis in 1 patient and wound infection in 1 patient. Among 86 patients, 80 patients(93%) pointed the painlessness as the best advantage of Dermabond(r). The cost was compared between Dermabond(r) and standard suture technique on similar facial laceration, resulted in 69,720 won vs. 43,747 won, which difference was not significant to most of the patients. Second follow-up evaluation was done 5 months after Dermabond(r) application. At this time, the quality of scar was compared by patients and two plastic surgeons. Among 63 patients included in second evaluation, 58 cases (92%) satisfied the scar qualities. Dermabond(r) is highly effective and satisfactory material for facial wound repair if the wound is properly selected.


2-Octylcyanoacrylate(Dermabond(r)); Tissue adhesive; Emergency department
Full Text Links
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr